Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions
The approach to patient engagement (PE) in drug development has changed rapidly due to many factors, including the complexity of innovative drugs and the need to demonstrate outcomes of relevance to patients, the desire to show 'value add' of PE, and the pandemic-related changes to how cli...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer Nature
2023
|
| _version_ | 1824458626193948672 |
|---|---|
| author | Faulkner, SD Somers, F Boudes, M Nafria, B Robinson, P |
| author_facet | Faulkner, SD Somers, F Boudes, M Nafria, B Robinson, P |
| author_sort | Faulkner, SD |
| collection | OXFORD |
| description | The approach to patient engagement (PE) in drug development has changed rapidly due to many factors, including the complexity of innovative drugs and the need to demonstrate outcomes of relevance to patients, the desire to show 'value add' of PE, and the pandemic-related changes to how clinical trials are run, e.g., decentralised studies. In parallel, there have been changes in technology-assisted ways of running clinical trials, capturing patient health outcomes and preferences, an increasing societal demand for diversity and inclusion, and efforts to improve clinical trial efficiency, transparency, and accountability. Organisations are beginning to monitor PE activities and outcomes more effectively to learn and inform future PE strategies. As a result, these factors are facilitating the incorporation of patients' lived experience, preferences and needs into the design and running of clinical trials more than ever before. In this paper, the authors reflect upon these last few years, the emerging trends and their drivers, and where we may expect PE in clinical research to progress in the near future. |
| first_indexed | 2025-02-19T04:28:53Z |
| format | Journal article |
| id | oxford-uuid:be0d4b70-2caf-4cc0-b200-d11e313a2ed2 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2025-02-19T04:28:53Z |
| publishDate | 2023 |
| publisher | Springer Nature |
| record_format | dspace |
| spelling | oxford-uuid:be0d4b70-2caf-4cc0-b200-d11e313a2ed22024-12-13T14:01:49ZUsing patient perspectives to inform better clinical trial design and conduct: current trends and future directionsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:be0d4b70-2caf-4cc0-b200-d11e313a2ed2EnglishSymplectic ElementsSpringer Nature2023Faulkner, SDSomers, FBoudes, MNafria, BRobinson, PThe approach to patient engagement (PE) in drug development has changed rapidly due to many factors, including the complexity of innovative drugs and the need to demonstrate outcomes of relevance to patients, the desire to show 'value add' of PE, and the pandemic-related changes to how clinical trials are run, e.g., decentralised studies. In parallel, there have been changes in technology-assisted ways of running clinical trials, capturing patient health outcomes and preferences, an increasing societal demand for diversity and inclusion, and efforts to improve clinical trial efficiency, transparency, and accountability. Organisations are beginning to monitor PE activities and outcomes more effectively to learn and inform future PE strategies. As a result, these factors are facilitating the incorporation of patients' lived experience, preferences and needs into the design and running of clinical trials more than ever before. In this paper, the authors reflect upon these last few years, the emerging trends and their drivers, and where we may expect PE in clinical research to progress in the near future. |
| spellingShingle | Faulkner, SD Somers, F Boudes, M Nafria, B Robinson, P Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions |
| title | Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions |
| title_full | Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions |
| title_fullStr | Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions |
| title_full_unstemmed | Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions |
| title_short | Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions |
| title_sort | using patient perspectives to inform better clinical trial design and conduct current trends and future directions |
| work_keys_str_mv | AT faulknersd usingpatientperspectivestoinformbetterclinicaltrialdesignandconductcurrenttrendsandfuturedirections AT somersf usingpatientperspectivestoinformbetterclinicaltrialdesignandconductcurrenttrendsandfuturedirections AT boudesm usingpatientperspectivestoinformbetterclinicaltrialdesignandconductcurrenttrendsandfuturedirections AT nafriab usingpatientperspectivestoinformbetterclinicaltrialdesignandconductcurrenttrendsandfuturedirections AT robinsonp usingpatientperspectivestoinformbetterclinicaltrialdesignandconductcurrenttrendsandfuturedirections |